Dow and Diversa Advance Enzyme Candidates for Production of Pharmaceutical Intermediates
21-Nov-2001 -
Midland, Michigan and San Diego, California - November 19, 2001 - The Dow Chemical Company (NYSE: Dow) and
Diversa Corporation (Nasdaq: DVSA) announced they have expanded their agreement to identify biocatalytic processes to
replace traditional and costly multi-step chemical synthesis.
The ...
active pharmaceutical ingredients
biotechnology
chemical synthesis
+17